M.D. Sass Concentrated Value ETF
SASS
4 hedge funds and large institutions have $68.2M invested in M.D. Sass Concentrated Value ETF in 2026 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
300% more funds holding
Funds holding: 1 → 4 (+3)
91.3% less ownership
Funds ownership: 91.3% → 0% (-91%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$635K |
| 2 |
5T Wealth
Napa,
California
|
+$606K |
| 3 |
GTS Securities
Miami,
Florida
|
+$221K |
| 4 |
M.D. Sass
New York
|
+$36.7K |
Top Sellers
SASS Hedge Fund Activity: Q3 2026 in Review
4 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in M.D. Sass Concentrated Value ETF (SASS) for Q3 2026, worth a combined $68.2M — down 5.6% from $72.2M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SASS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $635K.
- 4 institutional investors held M.D. Sass Concentrated Value ETF (SASS) as of Q3 2026, up from 1 in Q2 2026.
- Funds reported $68.2M of M.D. Sass Concentrated Value ETF stock for Q3 2026, down 5.6% quarter-over-quarter.
- 3 funds opened new M.D. Sass Concentrated Value ETF positions in Q3 2026 and 0 closed out, a net change of +3 holders.
- The largest M.D. Sass Concentrated Value ETF buyer in Q3 2026 was JP Morgan Chase, an estimated $635K added.
Based on aggregated 13F filings for Q3 2026.